What’s Next For OMass After Roche Licensing Deal

 
• By Manas Mishra
  
OMass Therapeutics CEO Rosamond Deegan
OMass Therapeutics CEO Rosamond Deegan (OMass Therapeutics)

More from Interviews

More from Leadership